Clinical Trial Update: Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating Acute Ischemic Stroke [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating infusion of umbilical cord-derived mesenchymal stem cells for acute ischemic stroke; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Umbilical Cord-derived Mesenchymal Stem Cell Infusion (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: National Engineering Center of Cell Products | Conditions: Acute Ischemic Stroke | Phase 1 | Status: NOT_YET_RECRUITING